COVID-19 Impact on Global Subcutaneous Injector, Market Insights and Forecast to 2026
Subcutaneous Injector market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Injector market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Subcutaneous Injector market is segmented into
The Subcutaneous Injector market is analysed and market size information is provided by regions (countries).
The key regions covered in the Subcutaneous Injector market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Subcutaneous Injector Market Share Analysis
Subcutaneous Injector market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Subcutaneous Injector by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Subcutaneous Injector business, the date to enter into the Subcutaneous Injector market, Subcutaneous Injector product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Subcutaneous Injector market is segmented into
- Fillable
- Prefilled
- Hospital
- Clinic
- Laboratory
- Others
The Subcutaneous Injector market is analysed and market size information is provided by regions (countries).
The key regions covered in the Subcutaneous Injector market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Subcutaneous Injector Market Share Analysis
Subcutaneous Injector market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Subcutaneous Injector by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Subcutaneous Injector business, the date to enter into the Subcutaneous Injector market, Subcutaneous Injector product introduction, recent developments, etc.
The major vendors covered:
- Antares Pharma
- Endo International
- PharmaJet
- Bioject Medical Technologies Inc
- Medical International Technology
- National Medical Products
- Valeritas
- European Pharma Group
1 STUDY COVERAGE
1.1 Subcutaneous Injector Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Subcutaneous Injector Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Subcutaneous Injector Market Size Growth Rate by Type
1.4.2 Fillable
1.4.3 Prefilled
1.5 Market by Application
1.5.1 Global Subcutaneous Injector Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Laboratory
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Injector Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Injector Industry
1.6.1.1 Subcutaneous Injector Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Injector Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Injector Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Subcutaneous Injector Market Size Estimates and Forecasts
2.1.1 Global Subcutaneous Injector Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Subcutaneous Injector Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Subcutaneous Injector Production Estimates and Forecasts 2015-2026
2.2 Global Subcutaneous Injector Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Subcutaneous Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Subcutaneous Injector Manufacturers Geographical Distribution
2.4 Key Trends for Subcutaneous Injector Markets & Products
2.5 Primary Interviews with Key Subcutaneous Injector Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Subcutaneous Injector Manufacturers by Production Capacity
3.1.1 Global Top Subcutaneous Injector Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Subcutaneous Injector Manufacturers by Production (2015-2020)
3.1.3 Global Top Subcutaneous Injector Manufacturers Market Share by Production
3.2 Global Top Subcutaneous Injector Manufacturers by Revenue
3.2.1 Global Top Subcutaneous Injector Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Subcutaneous Injector Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Injector Revenue in 2019
3.3 Global Subcutaneous Injector Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 SUBCUTANEOUS INJECTOR PRODUCTION BY REGIONS
4.1 Global Subcutaneous Injector Historic Market Facts & Figures by Regions
4.1.1 Global Top Subcutaneous Injector Regions by Production (2015-2020)
4.1.2 Global Top Subcutaneous Injector Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Subcutaneous Injector Production (2015-2020)
4.2.2 North America Subcutaneous Injector Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Subcutaneous Injector Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Subcutaneous Injector Production (2015-2020)
4.3.2 Europe Subcutaneous Injector Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Subcutaneous Injector Import & Export (2015-2020)
4.4 China
4.4.1 China Subcutaneous Injector Production (2015-2020)
4.4.2 China Subcutaneous Injector Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Subcutaneous Injector Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Subcutaneous Injector Production (2015-2020)
4.5.2 Japan Subcutaneous Injector Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Subcutaneous Injector Import & Export (2015-2020)
5 SUBCUTANEOUS INJECTOR CONSUMPTION BY REGION
5.1 Global Top Subcutaneous Injector Regions by Consumption
5.1.1 Global Top Subcutaneous Injector Regions by Consumption (2015-2020)
5.1.2 Global Top Subcutaneous Injector Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Subcutaneous Injector Consumption by Application
5.2.2 North America Subcutaneous Injector Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Subcutaneous Injector Consumption by Application
5.3.2 Europe Subcutaneous Injector Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Subcutaneous Injector Consumption by Application
5.4.2 Asia Pacific Subcutaneous Injector Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Subcutaneous Injector Consumption by Application
5.5.2 Central & South America Subcutaneous Injector Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Subcutaneous Injector Consumption by Application
5.6.2 Middle East and Africa Subcutaneous Injector Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Subcutaneous Injector Market Size by Type (2015-2020)
6.1.1 Global Subcutaneous Injector Production by Type (2015-2020)
6.1.2 Global Subcutaneous Injector Revenue by Type (2015-2020)
6.1.3 Subcutaneous Injector Price by Type (2015-2020)
6.2 Global Subcutaneous Injector Market Forecast by Type (2021-2026)
6.2.1 Global Subcutaneous Injector Production Forecast by Type (2021-2026)
6.2.2 Global Subcutaneous Injector Revenue Forecast by Type (2021-2026)
6.2.3 Global Subcutaneous Injector Price Forecast by Type (2021-2026)
6.3 Global Subcutaneous Injector Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Subcutaneous Injector Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Subcutaneous Injector Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Antares Pharma
8.1.1 Antares Pharma Corporation Information
8.1.2 Antares Pharma Overview and Its Total Revenue
8.1.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Antares Pharma Product Description
8.1.5 Antares Pharma Recent Development
8.2 Endo International
8.2.1 Endo International Corporation Information
8.2.2 Endo International Overview and Its Total Revenue
8.2.3 Endo International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Endo International Product Description
8.2.5 Endo International Recent Development
8.3 PharmaJet
8.3.1 PharmaJet Corporation Information
8.3.2 PharmaJet Overview and Its Total Revenue
8.3.3 PharmaJet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 PharmaJet Product Description
8.3.5 PharmaJet Recent Development
8.4 Bioject Medical Technologies Inc
8.4.1 Bioject Medical Technologies Inc Corporation Information
8.4.2 Bioject Medical Technologies Inc Overview and Its Total Revenue
8.4.3 Bioject Medical Technologies Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Bioject Medical Technologies Inc Product Description
8.4.5 Bioject Medical Technologies Inc Recent Development
8.5 Medical International Technology
8.5.1 Medical International Technology Corporation Information
8.5.2 Medical International Technology Overview and Its Total Revenue
8.5.3 Medical International Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medical International Technology Product Description
8.5.5 Medical International Technology Recent Development
8.6 National Medical Products
8.6.1 National Medical Products Corporation Information
8.6.2 National Medical Products Overview and Its Total Revenue
8.6.3 National Medical Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 National Medical Products Product Description
8.6.5 National Medical Products Recent Development
8.7 Valeritas
8.7.1 Valeritas Corporation Information
8.7.2 Valeritas Overview and Its Total Revenue
8.7.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Valeritas Product Description
8.7.5 Valeritas Recent Development
8.8 European Pharma Group
8.8.1 European Pharma Group Corporation Information
8.8.2 European Pharma Group Overview and Its Total Revenue
8.8.3 European Pharma Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 European Pharma Group Product Description
8.8.5 European Pharma Group Recent Development
8.9 PenJet Corporation
8.9.1 PenJet Corporation Corporation Information
8.9.2 PenJet Corporation Overview and Its Total Revenue
8.9.3 PenJet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 PenJet Corporation Product Description
8.9.5 PenJet Corporation Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Subcutaneous Injector Regions Forecast by Revenue (2021-2026)
9.2 Global Top Subcutaneous Injector Regions Forecast by Production (2021-2026)
9.3 Key Subcutaneous Injector Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 SUBCUTANEOUS INJECTOR CONSUMPTION FORECAST BY REGION
10.1 Global Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.2 North America Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.3 Europe Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.5 Latin America Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Subcutaneous Injector Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Subcutaneous Injector Sales Channels
11.2.2 Subcutaneous Injector Distributors
11.3 Subcutaneous Injector Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL SUBCUTANEOUS INJECTOR STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Subcutaneous Injector Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Subcutaneous Injector Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Subcutaneous Injector Market Size Growth Rate by Type
1.4.2 Fillable
1.4.3 Prefilled
1.5 Market by Application
1.5.1 Global Subcutaneous Injector Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Laboratory
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Injector Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Injector Industry
1.6.1.1 Subcutaneous Injector Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Injector Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Injector Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Subcutaneous Injector Market Size Estimates and Forecasts
2.1.1 Global Subcutaneous Injector Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Subcutaneous Injector Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Subcutaneous Injector Production Estimates and Forecasts 2015-2026
2.2 Global Subcutaneous Injector Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Subcutaneous Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Subcutaneous Injector Manufacturers Geographical Distribution
2.4 Key Trends for Subcutaneous Injector Markets & Products
2.5 Primary Interviews with Key Subcutaneous Injector Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Subcutaneous Injector Manufacturers by Production Capacity
3.1.1 Global Top Subcutaneous Injector Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Subcutaneous Injector Manufacturers by Production (2015-2020)
3.1.3 Global Top Subcutaneous Injector Manufacturers Market Share by Production
3.2 Global Top Subcutaneous Injector Manufacturers by Revenue
3.2.1 Global Top Subcutaneous Injector Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Subcutaneous Injector Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Injector Revenue in 2019
3.3 Global Subcutaneous Injector Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 SUBCUTANEOUS INJECTOR PRODUCTION BY REGIONS
4.1 Global Subcutaneous Injector Historic Market Facts & Figures by Regions
4.1.1 Global Top Subcutaneous Injector Regions by Production (2015-2020)
4.1.2 Global Top Subcutaneous Injector Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Subcutaneous Injector Production (2015-2020)
4.2.2 North America Subcutaneous Injector Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Subcutaneous Injector Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Subcutaneous Injector Production (2015-2020)
4.3.2 Europe Subcutaneous Injector Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Subcutaneous Injector Import & Export (2015-2020)
4.4 China
4.4.1 China Subcutaneous Injector Production (2015-2020)
4.4.2 China Subcutaneous Injector Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Subcutaneous Injector Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Subcutaneous Injector Production (2015-2020)
4.5.2 Japan Subcutaneous Injector Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Subcutaneous Injector Import & Export (2015-2020)
5 SUBCUTANEOUS INJECTOR CONSUMPTION BY REGION
5.1 Global Top Subcutaneous Injector Regions by Consumption
5.1.1 Global Top Subcutaneous Injector Regions by Consumption (2015-2020)
5.1.2 Global Top Subcutaneous Injector Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Subcutaneous Injector Consumption by Application
5.2.2 North America Subcutaneous Injector Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Subcutaneous Injector Consumption by Application
5.3.2 Europe Subcutaneous Injector Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Subcutaneous Injector Consumption by Application
5.4.2 Asia Pacific Subcutaneous Injector Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Subcutaneous Injector Consumption by Application
5.5.2 Central & South America Subcutaneous Injector Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Subcutaneous Injector Consumption by Application
5.6.2 Middle East and Africa Subcutaneous Injector Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Subcutaneous Injector Market Size by Type (2015-2020)
6.1.1 Global Subcutaneous Injector Production by Type (2015-2020)
6.1.2 Global Subcutaneous Injector Revenue by Type (2015-2020)
6.1.3 Subcutaneous Injector Price by Type (2015-2020)
6.2 Global Subcutaneous Injector Market Forecast by Type (2021-2026)
6.2.1 Global Subcutaneous Injector Production Forecast by Type (2021-2026)
6.2.2 Global Subcutaneous Injector Revenue Forecast by Type (2021-2026)
6.2.3 Global Subcutaneous Injector Price Forecast by Type (2021-2026)
6.3 Global Subcutaneous Injector Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Subcutaneous Injector Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Subcutaneous Injector Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Antares Pharma
8.1.1 Antares Pharma Corporation Information
8.1.2 Antares Pharma Overview and Its Total Revenue
8.1.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Antares Pharma Product Description
8.1.5 Antares Pharma Recent Development
8.2 Endo International
8.2.1 Endo International Corporation Information
8.2.2 Endo International Overview and Its Total Revenue
8.2.3 Endo International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Endo International Product Description
8.2.5 Endo International Recent Development
8.3 PharmaJet
8.3.1 PharmaJet Corporation Information
8.3.2 PharmaJet Overview and Its Total Revenue
8.3.3 PharmaJet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 PharmaJet Product Description
8.3.5 PharmaJet Recent Development
8.4 Bioject Medical Technologies Inc
8.4.1 Bioject Medical Technologies Inc Corporation Information
8.4.2 Bioject Medical Technologies Inc Overview and Its Total Revenue
8.4.3 Bioject Medical Technologies Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Bioject Medical Technologies Inc Product Description
8.4.5 Bioject Medical Technologies Inc Recent Development
8.5 Medical International Technology
8.5.1 Medical International Technology Corporation Information
8.5.2 Medical International Technology Overview and Its Total Revenue
8.5.3 Medical International Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medical International Technology Product Description
8.5.5 Medical International Technology Recent Development
8.6 National Medical Products
8.6.1 National Medical Products Corporation Information
8.6.2 National Medical Products Overview and Its Total Revenue
8.6.3 National Medical Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 National Medical Products Product Description
8.6.5 National Medical Products Recent Development
8.7 Valeritas
8.7.1 Valeritas Corporation Information
8.7.2 Valeritas Overview and Its Total Revenue
8.7.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Valeritas Product Description
8.7.5 Valeritas Recent Development
8.8 European Pharma Group
8.8.1 European Pharma Group Corporation Information
8.8.2 European Pharma Group Overview and Its Total Revenue
8.8.3 European Pharma Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 European Pharma Group Product Description
8.8.5 European Pharma Group Recent Development
8.9 PenJet Corporation
8.9.1 PenJet Corporation Corporation Information
8.9.2 PenJet Corporation Overview and Its Total Revenue
8.9.3 PenJet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 PenJet Corporation Product Description
8.9.5 PenJet Corporation Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Subcutaneous Injector Regions Forecast by Revenue (2021-2026)
9.2 Global Top Subcutaneous Injector Regions Forecast by Production (2021-2026)
9.3 Key Subcutaneous Injector Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 SUBCUTANEOUS INJECTOR CONSUMPTION FORECAST BY REGION
10.1 Global Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.2 North America Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.3 Europe Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.5 Latin America Subcutaneous Injector Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Subcutaneous Injector Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Subcutaneous Injector Sales Channels
11.2.2 Subcutaneous Injector Distributors
11.3 Subcutaneous Injector Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL SUBCUTANEOUS INJECTOR STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Subcutaneous Injector Key Market Segments in This Study
Table 2. Ranking of Global Top Subcutaneous Injector Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Injector Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Fillable
Table 5. Major Manufacturers of Prefilled
Table 6. COVID-19 Impact Global Market: (Four Subcutaneous Injector Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Subcutaneous Injector Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Subcutaneous Injector Players to Combat Covid-19 Impact
Table 11. Global Subcutaneous Injector Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Subcutaneous Injector Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Subcutaneous Injector by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injector as of 2019)
Table 15. Subcutaneous Injector Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Subcutaneous Injector Product Offered
Table 17. Date of Manufacturers Enter into Subcutaneous Injector Market
Table 18. Key Trends for Subcutaneous Injector Markets & Products
Table 19. Main Points Interviewed from Key Subcutaneous Injector Players
Table 20. Global Subcutaneous Injector Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Subcutaneous Injector Production Share by Manufacturers (2015-2020)
Table 22. Subcutaneous Injector Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Subcutaneous Injector Revenue Share by Manufacturers (2015-2020)
Table 24. Subcutaneous Injector Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Subcutaneous Injector Production by Regions (2015-2020) (K Units)
Table 27. Global Subcutaneous Injector Production Market Share by Regions (2015-2020)
Table 28. Global Subcutaneous Injector Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Subcutaneous Injector Revenue Market Share by Regions (2015-2020)
Table 30. Key Subcutaneous Injector Players in North America
Table 31. Import & Export of Subcutaneous Injector in North America (K Units)
Table 32. Key Subcutaneous Injector Players in Europe
Table 33. Import & Export of Subcutaneous Injector in Europe (K Units)
Table 34. Key Subcutaneous Injector Players in China
Table 35. Import & Export of Subcutaneous Injector in China (K Units)
Table 36. Key Subcutaneous Injector Players in Japan
Table 37. Import & Export of Subcutaneous Injector in Japan (K Units)
Table 38. Global Subcutaneous Injector Consumption by Regions (2015-2020) (K Units)
Table 39. Global Subcutaneous Injector Consumption Market Share by Regions (2015-2020)
Table 40. North America Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 41. North America Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 43. Europe Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Subcutaneous Injector Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Subcutaneous Injector Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 51. Global Subcutaneous Injector Production by Type (2015-2020) (K Units)
Table 52. Global Subcutaneous Injector Production Share by Type (2015-2020)
Table 53. Global Subcutaneous Injector Revenue by Type (2015-2020) (Million US$)
Table 54. Global Subcutaneous Injector Revenue Share by Type (2015-2020)
Table 55. Subcutaneous Injector Price by Type 2015-2020 (USD/Unit)
Table 56. Global Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 57. Global Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 58. Global Subcutaneous Injector Consumption Share by Application (2015-2020)
Table 59. Antares Pharma Corporation Information
Table 60. Antares Pharma Description and Major Businesses
Table 61. Antares Pharma Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Antares Pharma Product
Table 63. Antares Pharma Recent Development
Table 64. Endo International Corporation Information
Table 65. Endo International Description and Major Businesses
Table 66. Endo International Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Endo International Product
Table 68. Endo International Recent Development
Table 69. PharmaJet Corporation Information
Table 70. PharmaJet Description and Major Businesses
Table 71. PharmaJet Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. PharmaJet Product
Table 73. PharmaJet Recent Development
Table 74. Bioject Medical Technologies Inc Corporation Information
Table 75. Bioject Medical Technologies Inc Description and Major Businesses
Table 76. Bioject Medical Technologies Inc Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bioject Medical Technologies Inc Product
Table 78. Bioject Medical Technologies Inc Recent Development
Table 79. Medical International Technology Corporation Information
Table 80. Medical International Technology Description and Major Businesses
Table 81. Medical International Technology Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Medical International Technology Product
Table 83. Medical International Technology Recent Development
Table 84. National Medical Products Corporation Information
Table 85. National Medical Products Description and Major Businesses
Table 86. National Medical Products Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. National Medical Products Product
Table 88. National Medical Products Recent Development
Table 89. Valeritas Corporation Information
Table 90. Valeritas Description and Major Businesses
Table 91. Valeritas Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Valeritas Product
Table 93. Valeritas Recent Development
Table 94. European Pharma Group Corporation Information
Table 95. European Pharma Group Description and Major Businesses
Table 96. European Pharma Group Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. European Pharma Group Product
Table 98. European Pharma Group Recent Development
Table 99. PenJet Corporation Corporation Information
Table 100. PenJet Corporation Description and Major Businesses
Table 101. PenJet Corporation Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. PenJet Corporation Product
Table 103. PenJet Corporation Recent Development
Table 104. Global Subcutaneous Injector Revenue Forecast by Region (2021-2026) (Million US$)
Table 105. Global Subcutaneous Injector Production Forecast by Regions (2021-2026) (K Units)
Table 106. Global Subcutaneous Injector Production Forecast by Type (2021-2026) (K Units)
Table 107. Global Subcutaneous Injector Revenue Forecast by Type (2021-2026) (Million US$)
Table 108. North America Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 109. Europe Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 110. Asia Pacific Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 111. Latin America Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 112. Middle East and Africa Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 113. Subcutaneous Injector Distributors List
Table 114. Subcutaneous Injector Customers List
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 1. Subcutaneous Injector Key Market Segments in This Study
Table 2. Ranking of Global Top Subcutaneous Injector Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Injector Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Fillable
Table 5. Major Manufacturers of Prefilled
Table 6. COVID-19 Impact Global Market: (Four Subcutaneous Injector Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Subcutaneous Injector Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Subcutaneous Injector Players to Combat Covid-19 Impact
Table 11. Global Subcutaneous Injector Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Subcutaneous Injector Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Subcutaneous Injector by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injector as of 2019)
Table 15. Subcutaneous Injector Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Subcutaneous Injector Product Offered
Table 17. Date of Manufacturers Enter into Subcutaneous Injector Market
Table 18. Key Trends for Subcutaneous Injector Markets & Products
Table 19. Main Points Interviewed from Key Subcutaneous Injector Players
Table 20. Global Subcutaneous Injector Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Subcutaneous Injector Production Share by Manufacturers (2015-2020)
Table 22. Subcutaneous Injector Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Subcutaneous Injector Revenue Share by Manufacturers (2015-2020)
Table 24. Subcutaneous Injector Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Subcutaneous Injector Production by Regions (2015-2020) (K Units)
Table 27. Global Subcutaneous Injector Production Market Share by Regions (2015-2020)
Table 28. Global Subcutaneous Injector Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Subcutaneous Injector Revenue Market Share by Regions (2015-2020)
Table 30. Key Subcutaneous Injector Players in North America
Table 31. Import & Export of Subcutaneous Injector in North America (K Units)
Table 32. Key Subcutaneous Injector Players in Europe
Table 33. Import & Export of Subcutaneous Injector in Europe (K Units)
Table 34. Key Subcutaneous Injector Players in China
Table 35. Import & Export of Subcutaneous Injector in China (K Units)
Table 36. Key Subcutaneous Injector Players in Japan
Table 37. Import & Export of Subcutaneous Injector in Japan (K Units)
Table 38. Global Subcutaneous Injector Consumption by Regions (2015-2020) (K Units)
Table 39. Global Subcutaneous Injector Consumption Market Share by Regions (2015-2020)
Table 40. North America Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 41. North America Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 43. Europe Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Subcutaneous Injector Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Subcutaneous Injector Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Subcutaneous Injector Consumption by Countries (2015-2020) (K Units)
Table 51. Global Subcutaneous Injector Production by Type (2015-2020) (K Units)
Table 52. Global Subcutaneous Injector Production Share by Type (2015-2020)
Table 53. Global Subcutaneous Injector Revenue by Type (2015-2020) (Million US$)
Table 54. Global Subcutaneous Injector Revenue Share by Type (2015-2020)
Table 55. Subcutaneous Injector Price by Type 2015-2020 (USD/Unit)
Table 56. Global Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 57. Global Subcutaneous Injector Consumption by Application (2015-2020) (K Units)
Table 58. Global Subcutaneous Injector Consumption Share by Application (2015-2020)
Table 59. Antares Pharma Corporation Information
Table 60. Antares Pharma Description and Major Businesses
Table 61. Antares Pharma Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Antares Pharma Product
Table 63. Antares Pharma Recent Development
Table 64. Endo International Corporation Information
Table 65. Endo International Description and Major Businesses
Table 66. Endo International Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Endo International Product
Table 68. Endo International Recent Development
Table 69. PharmaJet Corporation Information
Table 70. PharmaJet Description and Major Businesses
Table 71. PharmaJet Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. PharmaJet Product
Table 73. PharmaJet Recent Development
Table 74. Bioject Medical Technologies Inc Corporation Information
Table 75. Bioject Medical Technologies Inc Description and Major Businesses
Table 76. Bioject Medical Technologies Inc Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bioject Medical Technologies Inc Product
Table 78. Bioject Medical Technologies Inc Recent Development
Table 79. Medical International Technology Corporation Information
Table 80. Medical International Technology Description and Major Businesses
Table 81. Medical International Technology Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Medical International Technology Product
Table 83. Medical International Technology Recent Development
Table 84. National Medical Products Corporation Information
Table 85. National Medical Products Description and Major Businesses
Table 86. National Medical Products Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. National Medical Products Product
Table 88. National Medical Products Recent Development
Table 89. Valeritas Corporation Information
Table 90. Valeritas Description and Major Businesses
Table 91. Valeritas Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Valeritas Product
Table 93. Valeritas Recent Development
Table 94. European Pharma Group Corporation Information
Table 95. European Pharma Group Description and Major Businesses
Table 96. European Pharma Group Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. European Pharma Group Product
Table 98. European Pharma Group Recent Development
Table 99. PenJet Corporation Corporation Information
Table 100. PenJet Corporation Description and Major Businesses
Table 101. PenJet Corporation Subcutaneous Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. PenJet Corporation Product
Table 103. PenJet Corporation Recent Development
Table 104. Global Subcutaneous Injector Revenue Forecast by Region (2021-2026) (Million US$)
Table 105. Global Subcutaneous Injector Production Forecast by Regions (2021-2026) (K Units)
Table 106. Global Subcutaneous Injector Production Forecast by Type (2021-2026) (K Units)
Table 107. Global Subcutaneous Injector Revenue Forecast by Type (2021-2026) (Million US$)
Table 108. North America Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 109. Europe Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 110. Asia Pacific Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 111. Latin America Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 112. Middle East and Africa Subcutaneous Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 113. Subcutaneous Injector Distributors List
Table 114. Subcutaneous Injector Customers List
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Subcutaneous Injector Product Picture
Figure 2. Global Subcutaneous Injector Production Market Share by Type in 2020 & 2026
Figure 3. Fillable Product Picture
Figure 4. Prefilled Product Picture
Figure 5. Global Subcutaneous Injector Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Laboratory
Figure 9. Others
Figure 10. Subcutaneous Injector Report Years Considered
Figure 11. Global Subcutaneous Injector Revenue 2015-2026 (Million US$)
Figure 12. Global Subcutaneous Injector Production Capacity 2015-2026 (K Units)
Figure 13. Global Subcutaneous Injector Production 2015-2026 (K Units)
Figure 14. Global Subcutaneous Injector Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Subcutaneous Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Subcutaneous Injector Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Subcutaneous Injector Revenue in 2019
Figure 18. Global Subcutaneous Injector Production Market Share by Region (2015-2020)
Figure 19. Subcutaneous Injector Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Subcutaneous Injector Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Subcutaneous Injector Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Subcutaneous Injector Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Subcutaneous Injector Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Subcutaneous Injector Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Subcutaneous Injector Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Subcutaneous Injector Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Subcutaneous Injector Consumption Market Share by Regions 2015-2020
Figure 28. North America Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 30. North America Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 31. U.S. Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 35. Europe Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 36. Germany Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Subcutaneous Injector Consumption Market Share by Regions in 2019
Figure 44. China Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 56. Latin America Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 57. Latin America Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 58. Mexico Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 64. Turkey Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Subcutaneous Injector Production Market Share by Type (2015-2020)
Figure 68. Global Subcutaneous Injector Production Market Share by Type in 2019
Figure 69. Global Subcutaneous Injector Revenue Market Share by Type (2015-2020)
Figure 70. Global Subcutaneous Injector Revenue Market Share by Type in 2019
Figure 71. Global Subcutaneous Injector Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Subcutaneous Injector Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Subcutaneous Injector Market Share by Price Range (2015-2020)
Figure 74. Global Subcutaneous Injector Consumption Market Share by Application (2015-2020)
Figure 75. Global Subcutaneous Injector Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Subcutaneous Injector Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. PharmaJet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Bioject Medical Technologies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Medical International Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. National Medical Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. European Pharma Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. PenJet Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Global Subcutaneous Injector Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 87. Global Subcutaneous Injector Revenue Market Share Forecast by Regions ((2021-2026))
Figure 88. Global Subcutaneous Injector Production Forecast by Regions (2021-2026) (K Units)
Figure 89. North America Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 90. North America Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 91. Europe Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 92. Europe Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 93. China Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 94. China Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 95. Japan Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 96. Japan Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Global Subcutaneous Injector Consumption Market Share Forecast by Region (2021-2026)
Figure 98. Subcutaneous Injector Value Chain
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed
Figure 1. Subcutaneous Injector Product Picture
Figure 2. Global Subcutaneous Injector Production Market Share by Type in 2020 & 2026
Figure 3. Fillable Product Picture
Figure 4. Prefilled Product Picture
Figure 5. Global Subcutaneous Injector Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Laboratory
Figure 9. Others
Figure 10. Subcutaneous Injector Report Years Considered
Figure 11. Global Subcutaneous Injector Revenue 2015-2026 (Million US$)
Figure 12. Global Subcutaneous Injector Production Capacity 2015-2026 (K Units)
Figure 13. Global Subcutaneous Injector Production 2015-2026 (K Units)
Figure 14. Global Subcutaneous Injector Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Subcutaneous Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Subcutaneous Injector Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Subcutaneous Injector Revenue in 2019
Figure 18. Global Subcutaneous Injector Production Market Share by Region (2015-2020)
Figure 19. Subcutaneous Injector Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Subcutaneous Injector Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Subcutaneous Injector Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Subcutaneous Injector Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Subcutaneous Injector Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Subcutaneous Injector Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Subcutaneous Injector Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Subcutaneous Injector Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Subcutaneous Injector Consumption Market Share by Regions 2015-2020
Figure 28. North America Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 30. North America Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 31. U.S. Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 35. Europe Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 36. Germany Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Subcutaneous Injector Consumption Market Share by Regions in 2019
Figure 44. China Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 56. Latin America Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 57. Latin America Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 58. Mexico Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Subcutaneous Injector Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Subcutaneous Injector Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Subcutaneous Injector Consumption Market Share by Countries in 2019
Figure 64. Turkey Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Subcutaneous Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Subcutaneous Injector Production Market Share by Type (2015-2020)
Figure 68. Global Subcutaneous Injector Production Market Share by Type in 2019
Figure 69. Global Subcutaneous Injector Revenue Market Share by Type (2015-2020)
Figure 70. Global Subcutaneous Injector Revenue Market Share by Type in 2019
Figure 71. Global Subcutaneous Injector Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Subcutaneous Injector Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Subcutaneous Injector Market Share by Price Range (2015-2020)
Figure 74. Global Subcutaneous Injector Consumption Market Share by Application (2015-2020)
Figure 75. Global Subcutaneous Injector Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Subcutaneous Injector Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. PharmaJet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Bioject Medical Technologies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Medical International Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. National Medical Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. European Pharma Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. PenJet Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Global Subcutaneous Injector Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 87. Global Subcutaneous Injector Revenue Market Share Forecast by Regions ((2021-2026))
Figure 88. Global Subcutaneous Injector Production Forecast by Regions (2021-2026) (K Units)
Figure 89. North America Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 90. North America Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 91. Europe Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 92. Europe Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 93. China Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 94. China Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 95. Japan Subcutaneous Injector Production Forecast (2021-2026) (K Units)
Figure 96. Japan Subcutaneous Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Global Subcutaneous Injector Consumption Market Share Forecast by Region (2021-2026)
Figure 98. Subcutaneous Injector Value Chain
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed
